Abstracts tagged "Wegener’s granulomatosis and vasculitis"

Abstract Number: 1770 • 2018 ACR/ARHP Annual Meeting
Subglottic Stenosis and Endobronchial Disease in Granulomatosis with Polyangiitis
Kaitlin Quinn^1,2, Cailin Sibley³, Alexander Gelbard⁴, Arlene Sirajuddin⁵, Marcela A. Ferrada⁶, Marcus Chen⁷, David Cuthbertson⁸, Simon Carette⁹, Nader A. Khalidi¹⁰, Curry L. Koening¹¹, Carol Langford¹², Carol A. McAlear¹³, Paul A. Monach¹⁴, Larry W. Moreland¹⁵, Christian Pagnoux¹⁶, Philip Seo¹⁷, Ulrich Specks¹⁸, Antoine G. Sreih¹⁹, Steven R. Ytterberg²⁰, Peter A. Merkel²¹ and Peter C. Grayson²², ¹Georgetown University Hospital, Washington, DC, ²Systemic Autoimmunity Branch, NIAMS, Bethesda, MD, ³Oregon Health & Science University, Portland, OR, ⁴Vanderbilt University Medical Center, Nashville, TN, ⁵National Institutes of Health, Bethesda, MD, ⁶Critical Care, National Institutes of Health, Bethesda, MD, ⁷NHLBI, National Institutes of Health, Bethesda, MD, ⁸Biostatistics and Informatics, Department of Pediatrics, Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, ⁹Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹⁰Rheumatology, McMaster University, Hamilton, ON, Canada, ¹¹Rheumatology, Division of Rheumatology, University of Utah, Salt Lake City, UT, ¹²Rheumatic and Immunologic Diseases, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, ¹³Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹⁴Section of Rheumatology, Boston University School of Medicine, Boston, MA, ¹⁵Division of Rheumatology and Clinical Immunology, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ¹⁶Division of Rheumatology, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, ¹⁷Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, MD, ¹⁸Mayo Clinic College of Medicine, Rochester, MN, ¹⁹Rheumatology, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, ²⁰Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ²¹University of Pennsylvania, Philadelphia, PA, ²²National Institute of Arthritis, Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD
Background/Purpose: Damage to the large airways is a devastating complication of granulomatosis with polyangiitis (GPA). Identification of patient subsets at particular risk for airway disease…
Abstract Number: 1929 • 2016 ACR/ARHP Annual Meeting
Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype
Pooja Bhadbhade¹, Mehrdad Maz², Lowell Tilzer³, Fred Plapp³ and Jason Springer¹, ¹Allergy, Clinical Immunology and Rheumatology, The University of Kansas Medical Center, Department of Internal Medicine, Division of Allergy, Clinical Immunology and Rheumatology, Kansas City, KS, ²Allergy, Clinical Immunology, and Rheumatology, The University of Kansas Medical Center, Department of Internal Medicine, Division of Allergy, Clinical Immunology and Rheumatology, Kansas City, KS, ³Pathology and Laboratory Medicine, The University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS
Background/Purpose: ANCAs are used as diagnostic markers in patients with autoimmune vasculitis such as Granulomatosis with polyangitis (GPA), Microscopic polyangitis (MPA), and Eosinophilic granulomatosis with…
Abstract Number: 1529 • 2012 ACR/ARHP Annual Meeting
Upper Airway Gene Expression Profiling in Granulomatosis with Polyangiitis
Peter C. Grayson¹, Katrina Steiling², Paul A. Monach³, Ji Xiao⁴, Xiaohui Zhang², Yuriy Alekseyev², Stephano Monti⁴, Avrum Spira⁵ and Peter A. Merkel⁶, ¹Section of Rheumatology & the Clinical Epidemiology Unit, Boston University School of Medicine, Vasculitis Center, Boston, MA, ²Computational Biomedicine, Boston University Medical Center, Boston, MA, ³Rheumatology, Boston University, Boston, MA, ⁴Computational Biomedicine, Boston University Medial Center, Boston, MA, ⁵Computational Biomedicine, Boston University School of Medicine, Boston, MA, ⁶University of Pennsylvania, Philadelphia, PA
Background/Purpose: Nasal disease occurs in the majority of patients with granulomatosis with polyangiitis (Wegener's, GPA) and is often a presenting symptom of the disease. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].